Quick Takeaways
- SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A for Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 7.4%.
- Date of event: 30 Sep 2025.
SUVRETTA CAPITAL MANAGEMENT, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA)
- Filing Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Reporting Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Symbol
- PVLA
- Shares outstanding
- 11,113,514 shares
- Disclosed Ownership
- 822,400 shares
- Ownership
- 7.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 17:31:00 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 20 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 7.4% ownership in Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 20 Dec 2024.
- Current filing was accepted on 13 Nov 2025, 17:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.4% | 822,400 | 0 | 822,400 | By: /s/ Andrew Nathanson | Andrew Nathanson, General Counsel and Chief Compliance Officer | |
| AVERILL MASTER FUND, LTD. | 6.5% | 714,463 | 0 | 714,463 | By: /s/ Andrew Nathanson | Andrew Nathanson, Authorized Signatory | |
| AARON COWEN | 7.4% | 822,400 | 0 | 822,400 | By: /s/ Aaron Cowen | Aaron Cowen |